Also called: AEDG, Epithalon, Epitalon Recovery Stack
Epitalon is a man-made peptide, which means it is a very short chain of building blocks called amino acids. Scientists created it in a lab to copy something the body makes in a small gland in the brain. It is sold online in powder form for lab research only. Some people who want to slow aging use it on their own, but it is not an approved medicine.
In lab and animal studies, Epitalon has been looked at for its effect on telomeres, which are like protective caps on the ends of our DNA. Researchers think it may wake up an enzyme called telomerase that helps keep these caps long. Longer caps may help cells stay healthy as they age. It has also been studied for how cells handle stress and control their growth cycle.
The big problem is that most of this research was done in cells and animals, not people. No health agency has checked that it is safe or works. Regulators in Argentina warn that injectable products like this sold online may be dirty, fake, or wrongly made, which can cause serious harm. It should only be handled in a proper research lab.
On July 24, 2026, PCAC voted 7–4 to recommend adding Epitalon to the Section 503A Bulks List. The recommendation is non-binding; FDA must still complete formal notice-and-comment rulemaking before Epitalon could be lawfully compounded under 503A. Epitalon is not currently on the 503A Bulks List, remains an unapproved new drug, and 503A compounding remains unlawful pending final FDA action.
Benefits
The main themes across 51 research studies, in plain language.
Research indicates potential neuroprotective effects, including the promotion of neuronal differentiation and upregulation of neurotrophic factors, which may support cognitive health.
Clinical and animal studies suggest the peptide may help preserve retinal morphology and function, potentially offering benefits for conditions like retinitis pigmentosa.
Research suggests this peptide activates telomerase and extends telomere length in human cells, potentially delaying cellular aging and extending the replicative lifespan of cell populations.
Studies in rodents and insects indicate that this peptide may extend both mean and maximum lifespan and reduce mortality rates associated with aging.
Research suggests the peptide acts as a senolytic, helping to eliminate senescent ('zombie') cells, which may improve tissue function and physical capacity in aged models.
Findings suggest the peptide may support the repair and functional maintenance of various tissues, including the heart, kidneys, and respiratory system.
Findings indicate that this peptide may modulate immune function by upregulating T-cells and natural killer cells, potentially restoring immune competence in aging subjects.
Evidence suggests the peptide upregulates endogenous antioxidant enzymes (like SOD and catalase) and helps reduce cellular damage caused by reactive oxygen species (ROS).
Studies suggest the peptide helps protect against DNA damage, reduces chromosomal aberrations, and may remodel chromatin structure to support youthful gene expression.
Research suggests the peptide may improve metabolic markers, including insulin sensitivity and glucose tolerance, while potentially reducing body fat accumulation.
Evidence suggests the peptide activates skin fibroblasts and stimulates collagen synthesis, which may support skin elasticity, wound healing, and tissue rejuvenation.
Studies indicate the peptide may protect against age-related decline in oocyte quality by reducing oxidative stress and preserving mitochondrial function.
Research points to a role in regulating the pineal gland and normalizing melatonin secretion, which may help restore healthy circadian rhythms and improve sleep quality.
Preclinical research suggests the peptide may inhibit spontaneous tumor development and reduce the incidence of cancer in animal models.
Evidence suggests the peptide may stabilize mitochondrial membranes and improve ATP production, potentially enhancing cellular energy metabolism and exercise tolerance.
You just read the research on Epitalon. The cheat-sheet maps the most-used peptide stacks — doses, timing, and what to check before buying — on one page.
No spam. Unsubscribe anytime.
1 reported routine — each line links to the source it came from.
Self-reported & vendor-suggested
Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.
General
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Safety
Adverse effects reported in the research and by community use.
Reported in research and community sources — not exhaustive. Discontinue use and consult a healthcare professional if side effects occur.
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
Epitalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on a pineal-derived peptide. In human somatic-cell studies it induced expression of telomerase components and lengthened telomeres (Khavinson, 2003), with reported antioxidant and neuroendocrine (geroprotective) effects. The evidence base is concentrated largely in one laboratory/Russian-language literature, with limited independent replication.
Evidence
Every claim above traces back to a source you can check — here are 18 of them.
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity
PubChem - Compound - Epitalon
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
Epitalon-activated telomerase enhance bovine oocyte maturation rate and post-thawed embryo development.
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy
The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy.
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.
Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising Properties.
Peptide Epitalon activates chromatin at the old age.
Effect of epithalon on the incidence of chromosome aberrations in senescence-accelerated mice.
Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He mice.
Pineal-regulating tetrapeptide epitalon improves eye retina condition in retinitis pigmentosa.
Effect of vilon and epithalon on activity of enzymes in epithelial and subepithelial layers in small intestine of old rats.
Effect of epithalon on the incidence of chromosome aberrations in senescence-accelerated mice.
Timeline
Key moments in Epitalon’s research and regulatory timeline — sourced and dated.
News
Dated, sourced reporting that mentions Epitalon.
A November 2025 New York Times explainer takes a skeptical consumer lens to the peptide-therapy craze, separating the few uses with reasonable evidence (topical GHK-Cu and Matrixyl-type peptides in skincare) from the largely unproven injectable and "biohacking" market (BPC-157, TB-500, epitalon, semax, selank). Dermatologists frame cosmetic peptides as "sidekicks, not hero ingredients," while endocrinologists warn that growth-hormone-releasing peptides like sermorelin and tesamorelin carry the same long-term risks as HGH — diabetes, certain cancers, and acromegaly. The piece notes that most longevity claims rest on cell-culture or animal data only, and that "research-grade" products have no quality controls.
On July 23–24, 2026, the FDA's Pharmacy Compounding Advisory Committee recommended adding six of seven reviewed peptides (BPC-157, KPV, TB-500, MOTS-c, Epitalon, Semax) to the Section 503A Bulks List and rejected Emideltide/DSIP. The vote is advisory only — not a final FDA decision and not legal authorization to compound. FDA must still complete formal notice-and-comment rulemaking (typically 12–24 months) before any change in legal status.
Wondering how Epitalon pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →Explore by goal
Related peptides
Compare
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.